HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for better calcium control in rare hormone disorder
Disease control Not yet recruitingThis Phase 3 trial is testing whether higher daily doses of an investigational long-acting parathyroid hormone drug (palopegteriparatide) are safe and more effective for adults with hypoparathyroidism. The study aims to help participants maintain normal blood calcium levels while…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Greek study aims to give voice to patients with rare hormone disorder
Knowledge-focused Not yet recruitingThis study aims to translate and validate a patient questionnaire about symptoms and quality of life for Greek people with hypoparathyroidism. It will involve 200 adults who are already on stable treatment for this chronic condition. The goal is to create a culturally relevant to…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Aristotle University Of Thessaloniki • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
Moms on thyroid drug help science: is medicine in their milk?
Knowledge-focused Not yet recruitingThis study aims to find out if a medication called palopegteriparatide (YORVIPATH), used to treat a rare hormone condition, passes into breast milk. It will observe 10 breastfeeding women who are already taking this drug as part of their regular care. Researchers will collect and…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Ascendis Pharma A/S • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC